Meda has signed an exclusive licensing agreement with Medivir for Xerese. Xerese is used for topical treatment of cold sores. Meda’s exclusive rights cover the US, Canada and Mexico. Meda will pay Medivir a total of $5 million in up-front and pre-launch milestones. Meda will also pay Medivir double-digit royalties on sales.
Top Posts
Inside Silico
Archives
- May 2013 (30)
- April 2013 (34)
- March 2013 (34)
- February 2013 (41)
- January 2013 (35)
- December 2012 (40)
- November 2012 (34)
- October 2012 (56)
- September 2012 (41)
- August 2012 (35)
- July 2012 (48)
- June 2012 (40)
- May 2012 (44)
- April 2012 (39)
- March 2012 (63)
- February 2012 (50)
- January 2012 (91)
- December 2011 (96)
- November 2011 (91)
- October 2011 (88)
- September 2011 (99)
- August 2011 (56)
- July 2011 (96)
- June 2011 (105)
- May 2011 (100)
- April 2011 (106)
- March 2011 (115)
- February 2011 (102)
- January 2011 (110)
- December 2010 (107)
- November 2010 (106)
- October 2010 (122)
- September 2010 (119)
- August 2010 (55)
- July 2010 (99)
- June 2010 (106)
- May 2010 (92)
- April 2010 (113)
- March 2010 (116)
- February 2010 (110)
- January 2010 (113)
- December 2009 (82)
- November 2009 (74)
- October 2009 (104)
- September 2009 (77)
- August 2009 (34)
- July 2009 (80)
- June 2009 (62)
- May 2009 (68)
- April 2009 (25)
- March 2009 (61)
- February 2009 (10)
- January 2009 (4)
- December 2008 (2)
- November 2008 (3)
- September 2008 (2)
- April 2008 (3)
- February 2008 (1)
- January 2008 (1)
- November 2007 (4)
- October 2007 (7)
- September 2007 (5)
- August 2007 (2)
- July 2007 (21)
Blogroll
- Avelient BioPharm Blog
- Biotech Blog
- Biotech News
- Bnet Health Care
- Bnet Pharma
- Drug Discovery Today
- FDA News
- FierceBiotech
- Health Economics Blog
- I Am Biotech
- James Hatton
- LifeSciences World
- MarketWatch
- MaRS Blog
- Medical News Today
- OnBioVC
- OneMedPlace
- Orange Book Blog
- Patent Docs
- Pathophilia
- Pharma Marketing Blog
- Pharma’s Cutting Edge
- Pharmaceutical Executive Magazine
- PR Newswire: Biotechnology
- PR Newswire: Medical/Pharmaceuticals
- The Antibody Blog
- The Biotech Weblog
- The Health Economics Blog
- The IN VIVO Blog
- The Pink Sheet Daily
- The RPM Report
- WSJ.com: Health Blog
Research
Social networks
Silico Research · Cutting edge research about partnering and alliances
